{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T13:14:58Z","timestamp":1791897298670,"version":"4.3.4"},"reference-count":217,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathology - Research and Practice"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.prp.2025.156053","type":"journal-article","created":{"date-parts":[[2025,5,30]],"date-time":"2025-05-30T09:33:47Z","timestamp":1748597627000},"page":"156053","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Combating oxidative stress in non-alcoholic fatty liver disease: From mechanisms to therapeutic strategies"],"prefix":"10.1016","volume":"272","author":[{"given":"Amr Ali Mohamed Abdelgawwad","family":"El-Sehrawy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdulsalam Najm","family":"Mohammed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jitendra","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaafaru Sani","family":"Mohammed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Roopashree","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aditya","family":"Kashyap","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bethanney","family":"Janney J","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samir","family":"Sahoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaker","family":"Al-Hasnaawei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yassir Mohammed","family":"Nasr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.prp.2025.156053_bib1","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.jceh.2019.09.005","article-title":"Natural history of simple steatosis or nonalcoholic fatty liver","volume":"10","author":"De","year":"2020","journal-title":"J. Clin. Exp. Hepatol."},{"issue":"2","key":"10.1016\/j.prp.2025.156053_bib2","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1111\/joim.13343","article-title":"Risk for hepatic and extra-hepatic outcomes in nonalcoholic fatty liver disease","volume":"292","author":"Hagstr\u00f6m","year":"2022","journal-title":"J. Intern. Med."},{"issue":"1","key":"10.1016\/j.prp.2025.156053_bib3","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/hep.29367","article-title":"The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the Study of Liver Diseases","volume":"67","author":"Chalasani","year":"2018","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.prp.2025.156053_bib4","first-page":"884","article-title":"Non-alcoholic fatty liver disease, metabolic syndrome, and type 2 diabetes mellitus: where do we stand today?","volume":"19","author":"Mitrovic","year":"2022","journal-title":"Arch. Med. Sci. AMS"},{"issue":"6","key":"10.1016\/j.prp.2025.156053_bib5","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1002\/hep.29845","article-title":"Time to step-up the fight against NAFLD","volume":"67","author":"Zhang","year":"2018","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.prp.2025.156053_bib6","article-title":"Vitamin E (\u03b1-Tocopherol): emerging clinical role and adverse risks of supplementation in adults","volume":"17","author":"Kaye","year":"2025","journal-title":"Cureus"},{"issue":"10","key":"10.1016\/j.prp.2025.156053_bib7","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.3390\/biomedicines12102328","article-title":"Comparative analysis of resmetirom vs. FGF21 analogs vs. GLP-1 agonists in MASLD and MASH: network meta-analysis of clinical trials","volume":"12","author":"Ayesh","year":"2024","journal-title":"Biomedicines"},{"issue":"25","key":"10.1016\/j.prp.2025.156053_bib8","doi-asserted-by":"crossref","first-page":"2890","DOI":"10.3748\/wjg.v28.i25.2890","article-title":"Non-alcoholic fatty liver disease and the impact of genetic, epigenetic and environmental factors in the offspring","volume":"28","author":"Wajsbrot","year":"2022","journal-title":"World J. Gastroenterol."},{"issue":"10","key":"10.1016\/j.prp.2025.156053_bib9","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.3390\/cells12101434","article-title":"Mitochondrial cholesterol metabolites in a bile acid synthetic pathway drive nonalcoholic fatty liver disease: a revised \u201ctwo-hit\u201d hypothesis","volume":"12","author":"Kakiyama","year":"2023","journal-title":"Cells"},{"issue":"27","key":"10.1016\/j.prp.2025.156053_bib10","doi-asserted-by":"crossref","first-page":"2974","DOI":"10.3748\/wjg.v24.i27.2974","article-title":"Pathogenesis of non-alcoholic fatty liver disease in children and adolescence: from \u201ctwo hit theory\u201d to \u201cmultiple hit model","volume":"24","author":"Fang","year":"2018","journal-title":"World J. Gastroenterol."},{"issue":"8","key":"10.1016\/j.prp.2025.156053_bib11","doi-asserted-by":"crossref","first-page":"822","DOI":"10.3390\/medicina57080822","article-title":"Phytotherapy as multi-hit therapy to confront the multiple pathophysiology in non-alcoholic fatty liver disease: a systematic review of experimental interventions","volume":"57","author":"Ore","year":"2021","journal-title":"Medicina"},{"issue":"10","key":"10.1016\/j.prp.2025.156053_bib12","doi-asserted-by":"crossref","first-page":"20704","DOI":"10.3390\/ijms141020704","article-title":"Multiple hits, including oxidative stress, as pathogenesis and treatment target in non-alcoholic steatohepatitis (NASH)","volume":"14","author":"Takaki","year":"2013","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.prp.2025.156053_bib13","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1016\/j.freeradbiomed.2013.08.174","article-title":"Free radical biology for medicine: learning from nonalcoholic fatty liver disease","volume":"65","author":"Serviddio","year":"2013","journal-title":"Free Radic. Biol. Med."},{"issue":"7","key":"10.1016\/j.prp.2025.156053_bib14","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1038\/s41580-020-0230-3","article-title":"Reactive oxygen species (ROS) as pleiotropic physiological signalling agents","volume":"21","author":"Sies","year":"2020","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"3","key":"10.1016\/j.prp.2025.156053_bib15","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1053\/j.gastro.2018.06.083","article-title":"Mitochondrial dysfunction and signaling in chronic liver diseases","volume":"155","author":"Mansouri","year":"2018","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.prp.2025.156053_bib16","doi-asserted-by":"crossref","first-page":"614","DOI":"10.3390\/diagnostics13040614","article-title":"The link between NAFLD and metabolic syndrome","volume":"13","author":"Radu","year":"2023","journal-title":"Diagnostics"},{"issue":"3","key":"10.1016\/j.prp.2025.156053_bib17","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1002\/hep.31420","article-title":"From NAFLD to MAFLD: implications of a premature change in terminology","volume":"73","author":"Younossi","year":"2021","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.prp.2025.156053_bib18","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/hep.28431","article-title":"Global epidemiology of nonalcoholic fatty liver disease\u2014meta-analytic assessment of prevalence, incidence, and outcomes","volume":"64","author":"Younossi","year":"2016","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.prp.2025.156053_bib19","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1097\/MCG.0000000000000666","article-title":"The association between nonalcoholic fatty liver disease and metabolic abnormalities in the United States population","volume":"51","author":"Jinjuvadia","year":"2017","journal-title":"J. Clin. Gastroenterol."},{"issue":"4","key":"10.1016\/j.prp.2025.156053_bib20","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.jhep.2019.06.021","article-title":"The global epidemiology of NAFLD and NASH in patients with type 2 diabetes: a systematic review and meta-analysis","volume":"71","author":"Younossi","year":"2019","journal-title":"J. Hepatol."},{"issue":"5","key":"10.1016\/j.prp.2025.156053_bib21","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/nrgastro.2010.41","article-title":"The role of fructose in the pathogenesis of NAFLD and the metabolic syndrome","volume":"7","author":"Lim","year":"2010","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"8","key":"10.1016\/j.prp.2025.156053_bib22","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1016\/j.metabol.2015.12.012","article-title":"The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD)","volume":"65","author":"Buzzetti","year":"2016","journal-title":"Metabolism"},{"issue":"2","key":"10.1016\/j.prp.2025.156053_bib23","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1007\/s40200-023-01293-3","article-title":"Unraveling the link between insulin resistance and non-alcoholic fatty liver disease (or metabolic dysfunction-associated steatotic liver disease): a narrative review","volume":"22","author":"Ziamanesh","year":"2023","journal-title":"J. Diabetes Metab. Disord."},{"issue":"02","key":"10.1016\/j.prp.2025.156053_bib24","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1590\/s0004-2803.202100000-24","article-title":"Performace of triglyceride-glucose index on diagnosis and staging of nafld in obese patients","volume":"58","author":"Smiderle","year":"2021","journal-title":"Arq. De. Gastroenterol."},{"issue":"7","key":"10.1016\/j.prp.2025.156053_bib25","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.3748\/wjg.v20.i7.1746","article-title":"Zara V. Modulation of hepatic steatosis by dietary fatty acids","volume":"20","author":"Ferramosca","year":"2014","journal-title":"World J. Gastroenterol. WJG"},{"issue":"12","key":"10.1016\/j.prp.2025.156053_bib26","doi-asserted-by":"crossref","first-page":"5679","DOI":"10.3390\/nu6125679","article-title":"The role of dietary sugars and de novo lipogenesis in non-alcoholic fatty liver disease","volume":"6","author":"Moore","year":"2014","journal-title":"Nutrients"},{"issue":"3","key":"10.1016\/j.prp.2025.156053_bib27","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1111\/j.1439-0396.2007.00752.x","article-title":"Liver lipid metabolism","volume":"92","author":"Nguyen","year":"2008","journal-title":"J. Anim. Physiol. Anim. Nutr."},{"issue":"8","key":"10.1016\/j.prp.2025.156053_bib28","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1080\/10715762.2019.1635691","article-title":"Oxidative stress biomarkers in the serum and plasma of patients with non-alcoholic fatty liver disease (NAFLD). Can plasma AGE be a marker of NAFLD? Oxidative stress biomarkers in NAFLD patients","volume":"53","author":"\u015awiderska","year":"2019","journal-title":"Free Radic. Res."},{"issue":"11","key":"10.1016\/j.prp.2025.156053_bib29","doi-asserted-by":"crossref","first-page":"854","DOI":"10.3109\/10715762.2013.830717","article-title":"Mitochondrial dysfunction in non-alcoholic fatty liver disease and insulin resistance: cause or consequence?","volume":"47","author":"Garc\u00eda-Ruiz","year":"2013","journal-title":"Free Radic. Res."},{"key":"10.1016\/j.prp.2025.156053_bib30","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.cotox.2017.11.002","article-title":"NF-\u03baB in oxidative stress","volume":"7","author":"Lingappan","year":"2018","journal-title":"Curr. Opin. Toxicol."},{"issue":"1","key":"10.1016\/j.prp.2025.156053_bib31","first-page":"3","article-title":"Mitochondrial electron transport chain, ROS generation and uncoupling","volume":"44","author":"Zhao","year":"2019","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.prp.2025.156053_bib32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12937-016-0186-5","article-title":"The importance of antioxidants which play the role in cellular response against oxidative\/nitrosative stress: current state","volume":"15","author":"Kurutas","year":"2015","journal-title":"Nutr. J."},{"key":"10.1016\/j.prp.2025.156053_bib33","article-title":"Cytochrome P450 2E1 should not be neglected for acetaminophen-induced liver injury in metabolic diseases with altered insulin levels or glucose homeostasis","author":"Massart","year":"2021","journal-title":"Elsevier"},{"issue":"4","key":"10.1016\/j.prp.2025.156053_bib34","doi-asserted-by":"crossref","first-page":"361","DOI":"10.5152\/tjg.2016.16106","article-title":"Role of oxidative stress and insulin resistance in disease severity of non-alcoholic fatty liver disease","volume":"27","author":"K\u00f6ro\u011flu","year":"2016","journal-title":"Turk. J. Gastroenterol."},{"issue":"4","key":"10.1016\/j.prp.2025.156053_bib35","first-page":"3659","article-title":"Influence of different concentrations of uric acid on oxidative stress in steatosis hepatocytes","volume":"15","author":"Cheng","year":"2018","journal-title":"Exp. Ther. Med."},{"issue":"4","key":"10.1016\/j.prp.2025.156053_bib36","doi-asserted-by":"crossref","first-page":"90","DOI":"10.4330\/wjc.v4.i4.90","article-title":"Role of advanced glycation end products in cardiovascular disease","volume":"4","author":"Hegab","year":"2012","journal-title":"World J. Cardiol."},{"issue":"7","key":"10.1016\/j.prp.2025.156053_bib37","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.1083\/jcb.201804161","article-title":"Glutathione metabolism in cancer progression and treatment resistance","volume":"217","author":"Bansal","year":"2018","journal-title":"J. Cell Biol."},{"issue":"3","key":"10.1016\/j.prp.2025.156053_bib38","doi-asserted-by":"crossref","first-page":"644","DOI":"10.3390\/biomedicines13030644","article-title":"A literature review of glutathione therapy in ameliorating hepatic dysfunction in non-alcoholic fatty liver disease","volume":"13","author":"Nguyen","year":"2025","journal-title":"Biomedicines"},{"issue":"8","key":"10.1016\/j.prp.2025.156053_bib39","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1080\/10715762.2019.1635691","article-title":"Oxidative stress biomarkers in the serum and plasma of patients with non-alcoholic fatty liver disease (NAFLD). Can plasma AGE be a marker of NAFLD? Oxidative stress biomarkers in NAFLD patients","volume":"53","author":"\u015awiderska","year":"2019","journal-title":"Free Radic. Res."},{"issue":"10","key":"10.1016\/j.prp.2025.156053_bib40","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.1111\/liv.14940","article-title":"Hepatic macrophages: key players in the development and progression of liver fibrosis","volume":"41","author":"Cheng","year":"2021","journal-title":"Liver Int."},{"issue":"1","key":"10.1016\/j.prp.2025.156053_bib41","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1002\/hep.26607","article-title":"M2 Kupffer cells promote M1 Kupffer cell apoptosis: a protective mechanism against alcoholic and nonalcoholic fatty liver disease","volume":"59","author":"Wan","year":"2014","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.prp.2025.156053_bib42","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1172\/JCI26498","article-title":"MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity","volume":"116","author":"Kanda","year":"2006","journal-title":"J. Clin. Investig."},{"issue":"4","key":"10.1016\/j.prp.2025.156053_bib43","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0153118","article-title":"Characterization of the MMP\/TIMP imbalance and collagen production induced by IL-1\u03b2 or TNF-\u03b1 release from human hepatic stellate cells","volume":"11","author":"Robert","year":"2016","journal-title":"PloS One"},{"issue":"2","key":"10.1016\/j.prp.2025.156053_bib44","doi-asserted-by":"crossref","first-page":"472","DOI":"10.3390\/biom5020472","article-title":"Biological activities of reactive oxygen and nitrogen species: oxidative stress versus signal transduction","volume":"5","author":"Weidinger","year":"2015","journal-title":"Biomolecules"},{"key":"10.1016\/j.prp.2025.156053_bib45","doi-asserted-by":"crossref","unstructured":"Krumova K., Cosa G. Overview of Reactive Oxygen Species, 2016.","DOI":"10.1039\/9781782622208-00001"},{"issue":"1","key":"10.1016\/j.prp.2025.156053_bib46","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.tplants.2016.08.002","article-title":"ROS are good","volume":"22","author":"Mittler","year":"2017","journal-title":"Trends Plant Sci."},{"issue":"9","key":"10.1016\/j.prp.2025.156053_bib47","doi-asserted-by":"crossref","first-page":"4642","DOI":"10.3390\/ijms22094642","article-title":"The chemistry of reactive oxygen species (ROS) revisited: outlining their role in biological macromolecules (DNA, lipids and proteins) and induced pathologies","volume":"22","author":"Juan","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.prp.2025.156053_bib48","doi-asserted-by":"crossref","DOI":"10.1016\/j.arres.2022.100039","article-title":"Reactive Oxygen Species (ROS) and Reactive Nitrogen Species (RNS) in plants\u2013maintenance of structural individuality and functional blend","volume":"5","author":"Mandal","year":"2022","journal-title":"Adv. Redox Res."},{"issue":"7","key":"10.1016\/j.prp.2025.156053_bib49","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1093\/eurheartj\/ehr304","article-title":"Nitric oxide synthases: regulation and function","volume":"33","author":"F\u00f6rstermann","year":"2012","journal-title":"Eur. Heart J."},{"issue":"22","key":"10.1016\/j.prp.2025.156053_bib50","doi-asserted-by":"crossref","first-page":"3704","DOI":"10.3390\/cells11223704","article-title":"The role of NO\/sGC\/cGMP\/PKG signaling pathway in regulation of platelet function","volume":"11","author":"Gambaryan","year":"2022","journal-title":"Cells"},{"issue":"2","key":"10.1016\/j.prp.2025.156053_bib51","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1002\/biof.1150","article-title":"Peroxynitrite, a potent macrophage-derived oxidizing cytotoxin to combat invading pathogens","volume":"40","author":"Prolo","year":"2014","journal-title":"Biofactors"},{"issue":"1","key":"10.1016\/j.prp.2025.156053_bib52","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1006\/abbi.1994.1013","article-title":"Inhibition of mitochondrial electron transport by peroxynitrite","volume":"308","author":"Radi","year":"1994","journal-title":"Arch. Biochem. Biophys."},{"issue":"7","key":"10.1016\/j.prp.2025.156053_bib53","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/S0891-5849(00)00512-8","article-title":"Modulation of catalase peroxidatic and catalatic activity by nitric oxide","volume":"30","author":"Brunelli","year":"2001","journal-title":"Free Radic. Biol. Med."},{"issue":"37","key":"10.1016\/j.prp.2025.156053_bib54","doi-asserted-by":"crossref","first-page":"26464","DOI":"10.1074\/jbc.R113.472936","article-title":"Peroxynitrite, a stealthy biological oxidant","volume":"288","author":"Radi","year":"2013","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.prp.2025.156053_bib55","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.redox.2016.01.009","article-title":"Effects of high fat diets on rodent liver bioenergetics and oxidative imbalance","volume":"8","author":"Kakimoto","year":"2016","journal-title":"Redox Biol."},{"issue":"1-2","key":"10.1016\/j.prp.2025.156053_bib56","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/S0891-5849(98)00196-8","article-title":"Biomarkers of free radical damage: applications in experimental animals and in humans","volume":"26","author":"de Zwart","year":"1999","journal-title":"Free Radic. Biol. Med."},{"issue":"9","key":"10.1016\/j.prp.2025.156053_bib57","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1016\/S0891-5849(02)00910-3","article-title":"Rate of generation of oxidative stress-related damage and animal longevity","volume":"33","author":"Barja","year":"2002","journal-title":"Free Radic. Biol. Med."},{"issue":"2","key":"10.1016\/j.prp.2025.156053_bib58","first-page":"161","article-title":"Mitochondrial dysfunction and antioxidant therapy in sepsis","volume":"12","author":"Rocha","year":"2012","journal-title":"Infect. Disord. -Drug Targets (Former. Curr. Drug Targets-Infect. Disord. )"},{"key":"10.1016\/j.prp.2025.156053_bib59","doi-asserted-by":"crossref","first-page":"56","DOI":"10.3389\/fnbeh.2018.00056","article-title":"Aggression, social stress, and the immune system in humans and animal models","volume":"12","author":"Takahashi","year":"2018","journal-title":"Front Behav. Neurosci."},{"issue":"5","key":"10.1016\/j.prp.2025.156053_bib60","doi-asserted-by":"crossref","DOI":"10.1242\/jeb.221606","article-title":"Are mitochondria the main contributor of reactive oxygen species in cells?","volume":"224","author":"Zhang","year":"2021","journal-title":"J. Exp. Biol."},{"issue":"1","key":"10.1016\/j.prp.2025.156053_bib61","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1042\/BJ20081386","article-title":"How mitochondria produce reactive oxygen species","volume":"417","author":"Murphy","year":"2009","journal-title":"Biochem. J."},{"key":"10.1016\/j.prp.2025.156053_bib62","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/978-981-10-7757-9_7","article-title":"Mitochondrial respiratory chain complexes","author":"Sousa","year":"2018","journal-title":"Membr. Protein Complex. Struct. Funct."},{"issue":"2","key":"10.1016\/j.prp.2025.156053_bib63","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/0003-9861(77)90035-2","article-title":"Production of superoxide radicals and hydrogen peroxide by NADH-ubiquinone reductase and ubiquinol-cytochrome c reductase from beef-heart mitochondria","volume":"180","author":"Cadenas","year":"1977","journal-title":"Arch. Biochem. Biophys."},{"issue":"3","key":"10.1016\/j.prp.2025.156053_bib64","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1080\/15216549600201103","article-title":"Superoxide production by mitochondria in the presence of nitric oxide forms peroxynitrite","volume":"40","author":"Packer","year":"1996","journal-title":"IUBMB Life"},{"issue":"33","key":"10.1016\/j.prp.2025.156053_bib65","doi-asserted-by":"crossref","first-page":"24407","DOI":"10.1074\/jbc.M701589200","article-title":"Catalase takes part in rat liver mitochondria oxidative stress defense","volume":"282","author":"Salvi","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.prp.2025.156053_bib66","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1756-6614-5-24","article-title":"High level of oxidized nucleosides in thyroid mitochondrial DNA; damaging effects of Fenton reaction substrates","volume":"5","author":"Karbownik-Lewi\u0144ska","year":"2012","journal-title":"Thyroid Res."},{"issue":"16","key":"10.1016\/j.prp.2025.156053_bib67","doi-asserted-by":"crossref","first-page":"8969","DOI":"10.3390\/ijms22168969","article-title":"Mechanisms mediating the regulation of peroxisomal fatty acid beta-oxidation by PPAR\u03b1","volume":"22","author":"Tahri-Joutey","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.prp.2025.156053_bib68","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.biochi.2013.07.026","article-title":"Peroxisomal metabolism and oxidative stress","volume":"98","author":"Nordgren","year":"2014","journal-title":"Biochimie"},{"issue":"7","key":"10.1016\/j.prp.2025.156053_bib69","first-page":"1364","article-title":"ROS generation in peroxisomes and its role in cell signaling","volume":"57","author":"Del R\u00edo","year":"2016","journal-title":"Plant Cell Physiol."},{"key":"10.1016\/j.prp.2025.156053_bib70","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2022.858142","article-title":"Pathways linking nicotinamide adenine dinucleotide phosphate production to endoplasmic reticulum protein oxidation and stress","volume":"9","author":"Gansemer","year":"2022","journal-title":"Front. Mol. Biosci."},{"issue":"13","key":"10.1016\/j.prp.2025.156053_bib71","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1089\/ars.2021.0018","article-title":"ERO1-PDI redox signaling in health and disease","volume":"35","author":"Jha","year":"2021","journal-title":"Antioxid. Redox Signal."},{"issue":"19","key":"10.1016\/j.prp.2025.156053_bib72","doi-asserted-by":"crossref","first-page":"9235","DOI":"10.1080\/07391102.2021.1925154","article-title":"Mechanism of electron transfers mediated by cytochromes c and b 5 in mitochondria and endoplasmic reticulum: classical and murburn perspectives","volume":"40","author":"Gideon","year":"2022","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.prp.2025.156053_bib73","series-title":"Peroxiporins","first-page":"54","article-title":"H2O2\/ROS Production, Consumption, and Transport across Organelles","author":"Konno","year":"2023"},{"issue":"1","key":"10.1016\/j.prp.2025.156053_bib74","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.cell.2018.08.020","article-title":"ER stress drives lipogenesis and steatohepatitis via caspase-2 activation of S1P","volume":"175","author":"Kim","year":"2018","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.prp.2025.156053_bib75","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/9547613","article-title":"Role of oxidative stress in pathophysiology of nonalcoholic fatty liver disease","volume":"2018","author":"Masarone","year":"2018","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.prp.2025.156053_bib76","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.freeradbiomed.2020.02.025","article-title":"Role of oxidative stress in the pathogenesis of nonalcoholic fatty liver disease","volume":"152","author":"Chen","year":"2020","journal-title":"Free Radic. Biol. Med."},{"issue":"6","key":"10.1016\/j.prp.2025.156053_bib77","doi-asserted-by":"crossref","first-page":"890","DOI":"10.3390\/antiox10060890","article-title":"NADPH oxidases (NOX): an overview from discovery, molecular mechanisms to physiology and pathology","volume":"10","author":"Vermot","year":"2021","journal-title":"Antioxidants"},{"key":"10.1016\/j.prp.2025.156053_bib78","series-title":"Sustained Energy for Enhanced Human Functions and Activity","first-page":"385","article-title":"Antioxidants and vitamins: Roles in cellular function and metabolism","author":"Singh","year":"2017"},{"issue":"18","key":"10.1016\/j.prp.2025.156053_bib79","doi-asserted-by":"crossref","first-page":"5463","DOI":"10.1111\/febs.16336","article-title":"Nrf2 and oxidative stress in liver ischemia\/reperfusion injury","volume":"289","author":"G. Bardallo","year":"2022","journal-title":"FEBS J."},{"issue":"15","key":"10.1016\/j.prp.2025.156053_bib80","doi-asserted-by":"crossref","first-page":"8713","DOI":"10.3390\/ijms23158713","article-title":"Effect of physical activity\/exercise on oxidative stress and inflammation in muscle and vascular aging","volume":"23","author":"El Assar","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"10","key":"10.1016\/j.prp.2025.156053_bib81","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/j.neurol.2019.08.005","article-title":"Mediterranean diet: the role of long-chain \u03c9-3 fatty acids in fish; polyphenols in fruits, vegetables, cereals, coffee, tea, cacao and wine; probiotics and vitamins in prevention of stroke, age-related cognitive decline, and Alzheimer disease","volume":"175","author":"Roman","year":"2019","journal-title":"Rev. Neurol."},{"key":"10.1016\/j.prp.2025.156053_bib82","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2020.101635","article-title":"Exercise and dietary intervention ameliorate high-fat diet-induced NAFLD and liver aging by inducing lipophagy","volume":"36","author":"Gao","year":"2020","journal-title":"Redox Biol."},{"issue":"2","key":"10.1016\/j.prp.2025.156053_bib83","doi-asserted-by":"crossref","first-page":"322","DOI":"10.3390\/biomedicines11020322","article-title":"Effects of a combination of empagliflozin plus metformin vs. metformin monotherapy on NAFLD progression in type 2 diabetes: the IMAGIN pilot study","volume":"11","author":"Caturano","year":"2023","journal-title":"Biomedicines"},{"issue":"3","key":"10.1016\/j.prp.2025.156053_bib84","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2019.165621","article-title":"Protective effect of metformin against palmitate-induced hepatic cell death","volume":"1866","author":"Geng","year":"2020","journal-title":"Biochim. Biophys. Acta (BBA) Mol. Basis Dis."},{"issue":"10","key":"10.1016\/j.prp.2025.156053_bib85","doi-asserted-by":"crossref","first-page":"2863","DOI":"10.3390\/ijms19102863","article-title":"Metformin: an old drug with new applications","volume":"19","author":"Zhou","year":"2018","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.prp.2025.156053_bib86","doi-asserted-by":"crossref","first-page":"6668","DOI":"10.1038\/s41598-019-43228-0","article-title":"Metformin attenuates the onset of non-alcoholic fatty liver disease and affects intestinal microbiota and barrier in small intestine","volume":"9","author":"Brandt","year":"2019","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.prp.2025.156053_bib87","doi-asserted-by":"crossref","first-page":"46","DOI":"10.4161\/15548627.2014.984271","article-title":"Metformin alleviates hepatosteatosis by restoring SIRT1-mediated autophagy induction via an AMP-activated protein kinase-independent pathway","volume":"11","author":"Song","year":"2015","journal-title":"Autophagy"},{"issue":"4","key":"10.1016\/j.prp.2025.156053_bib88","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1586\/17474124.2014.894880","article-title":"Metformin in the treatment of non-alcoholic fatty liver disease: safety, efficacy and mechanism","volume":"8","author":"Rouabhia","year":"2014","journal-title":"Expert Rev. Gastroenterol. Hepatol."},{"issue":"1","key":"10.1016\/j.prp.2025.156053_bib89","article-title":"The role of metformin in the management of NAFLD","volume":"2012","author":"Mazza","year":"2012","journal-title":"J. Diabetes Res."},{"issue":"14","key":"10.1016\/j.prp.2025.156053_bib90","doi-asserted-by":"crossref","first-page":"4127","DOI":"10.3390\/jcm13144127","article-title":"Anti-inflammatory and anti-oxidant properties of N-acetylcysteine: a fresh perspective","volume":"13","author":"Santus","year":"2024","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.prp.2025.156053_bib91","doi-asserted-by":"crossref","first-page":"221","DOI":"10.3389\/fimmu.2014.00221","article-title":"Role of toll-like receptors in immune activation and tolerance in the liver","volume":"5","author":"Nakamoto","year":"2014","journal-title":"Front. Immunol."},{"issue":"2-3","key":"10.1016\/j.prp.2025.156053_bib92","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/S0014-5793(00)01464-2","article-title":"N-Acetylcysteine suppresses TNF-induced NF-\u03baB activation through inhibition of I\u03baB kinases","volume":"472","author":"Oka","year":"2000","journal-title":"FEBS Lett."},{"issue":"3-4","key":"10.1016\/j.prp.2025.156053_bib93","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.vetimm.2013.01.013","article-title":"The combination effects of acetaminophen and N-acetylcysteine on cytokines production and NF-\u03baB activation of lipopolysaccharide-challenged piglet mononuclear phagocytes in vitro and in vivo","volume":"152","author":"Qiu","year":"2013","journal-title":"Vet. Immunol. Immunopathol."},{"issue":"8","key":"10.1016\/j.prp.2025.156053_bib94","doi-asserted-by":"crossref","first-page":"4117","DOI":"10.1016\/j.bbagen.2013.04.016","article-title":"The chemistry and biological activities of N-acetylcysteine","volume":"1830","author":"Samuni","year":"2013","journal-title":"Biochim. Et. Biophys. Acta (BBA)-Gen. Subj."},{"issue":"10","key":"10.1016\/j.prp.2025.156053_bib95","doi-asserted-by":"crossref","first-page":"2515","DOI":"10.3748\/wjg.v20.i10.2515","article-title":"Hepatic inflammation and progressive liver fibrosis in chronic liver disease","volume":"20","author":"Czaja","year":"2014","journal-title":"World J. Gastroenterol. WJG"},{"issue":"1","key":"10.1016\/j.prp.2025.156053_bib96","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.pupt.2005.12.007","article-title":"Antioxidant and anti-inflammatory efficacy of NAC in the treatment of COPD: discordant in vitro and in vivo dose-effects: a review","volume":"20","author":"Sadowska","year":"2007","journal-title":"Pulm. Pharmacol. Ther."},{"issue":"10","key":"10.1016\/j.prp.2025.156053_bib97","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1093\/jn\/138.10.1872","article-title":"N-acetylcysteine attenuates progression of liver pathology in a rat model of nonalcoholic steatohepatitis3","volume":"138","author":"Baumgardner","year":"2008","journal-title":"J. Nutr."},{"issue":"1","key":"10.1016\/j.prp.2025.156053_bib98","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1093\/alcalc\/agt167","article-title":"Notch1-nuclear factor \u03baB involves in oxidative stress-induced alcoholic steatohepatitis","volume":"49","author":"Wang","year":"2014","journal-title":"Alcohol. Alcohol."},{"issue":"7","key":"10.1016\/j.prp.2025.156053_bib99","first-page":"1198","article-title":"Protective effect of ursodeoxycholic acid, resveratrol, and N-acetylcysteine on nonalcoholic fatty liver disease in rats","volume":"54","author":"Ali","year":"2016","journal-title":"Pharm. Biol."},{"issue":"11","key":"10.1016\/j.prp.2025.156053_bib100","first-page":"5351","article-title":"N, N\u2019-diacetylcystine ameliorates inflammation in experimental non-alcoholic steatohepatitis by regulating nuclear transcription factor kappa B activation","volume":"11","author":"Wang","year":"2018","journal-title":"Int. J. Clin. Exp. Pathol."},{"issue":"3","key":"10.1016\/j.prp.2025.156053_bib101","first-page":"670","article-title":"The effects ofN-acetylcysteine and anti-intercellular adhesion molecule-1 monoclonal antibody against ischemia-reperfusion injury of the rat steatotic liver produced by a choline-methionine-deficient diet","volume":"26","author":"Nakano","year":"1997","journal-title":"Hepatology"},{"issue":"12","key":"10.1016\/j.prp.2025.156053_bib102","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.3748\/wjg.v12.i12.1905","article-title":"Oral administration of S-nitroso-N-acetylcysteine prevents the onset of non alcoholic fatty liver disease in rats","volume":"12","author":"de Oliveira","year":"2006","journal-title":"World J. Gastroenterol. WJG"},{"issue":"10","key":"10.1016\/j.prp.2025.156053_bib103","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1046\/j.1440-1746.2003.03156.x","article-title":"N-acetylcysteine in the treatment of non-alcoholic steatohepatitis","volume":"18","author":"Emel Pamuk","year":"2003","journal-title":"J. Gastroenterol. Hepatol."},{"issue":"02","key":"10.1016\/j.prp.2025.156053_bib104","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1590\/s0004-2803.201900000-36","article-title":"N-acetylcysteine and\/or ursodeoxycholic acid associated with metformin in non-alcoholic steatohepatitis: an open-label multicenter randomized controlled trial","volume":"56","author":"Oliveira","year":"2019","journal-title":"Arq. De. Gastroenterol."},{"key":"10.1016\/j.prp.2025.156053_bib105","doi-asserted-by":"crossref","unstructured":"Sagias F.G., Mitry R.R., Hughes R.D., Lehec S.C., Patel A.G., Rela M., et al. N-acetylcysteine improves the viability of human hepatocytes isolated from severely steatotic donor liver tissue. SAGE Publications Sage CA: Los Angeles, CA; 2010.","DOI":"10.3727\/096368910X514620"},{"issue":"6","key":"10.1016\/j.prp.2025.156053_bib106","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1016\/S0015-0282(02)03133-3","article-title":"N-acetyl-cysteine treatment improves insulin sensitivity in women with polycystic ovary syndrome","volume":"77","author":"Fulghesu","year":"2002","journal-title":"Fertil. Steril."},{"issue":"8","key":"10.1016\/j.prp.2025.156053_bib107","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.3390\/antiox10081325","article-title":"Role of coenzyme Q10 in health and disease: an update on the last 10 years (2010\u20132020)","volume":"10","author":"Cirilli","year":"2021","journal-title":"Antioxidants"},{"issue":"21","key":"10.1016\/j.prp.2025.156053_bib108","doi-asserted-by":"crossref","first-page":"7870","DOI":"10.3390\/ijms21217870","article-title":"Coenzyme Q10 supplementation for the reduction of oxidative stress: clinical implications in the treatment of chronic diseases","volume":"21","author":"Gutierrez-Mariscal","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.prp.2025.156053_bib109","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1042\/EBC20170106","article-title":"Coenzyme Q10 deficiencies: pathways in yeast and humans","volume":"62","author":"Awad","year":"2018","journal-title":"Essays Biochem."},{"issue":"2","key":"10.1016\/j.prp.2025.156053_bib110","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1039\/C8FO01236A","article-title":"Coenzyme Q10 attenuates high-fat diet-induced non-alcoholic fatty liver disease through activation of the AMPK pathway","volume":"10","author":"Chen","year":"2019","journal-title":"Food Funct."},{"issue":"10","key":"10.1016\/j.prp.2025.156053_bib111","doi-asserted-by":"crossref","DOI":"10.5812\/ircmj.16433","article-title":"Effects of coenzyme q10 supplementation on serum lipoproteins, plasma fibrinogen, and blood pressure in patients with hyperlipidemia and myocardial infarction","volume":"16","author":"Mohseni","year":"2014","journal-title":"Iran. Red. Crescent Med. J."},{"issue":"1","key":"10.1016\/j.prp.2025.156053_bib112","doi-asserted-by":"crossref","first-page":"62","DOI":"10.3164\/jcbn.08-182","article-title":"In vitro effects of the reduced form of coenzyme Q10 on secretion levels of TNF-\u03b1 and chemokines in response to LPS in the human monocytic cell line THP-1","volume":"44","author":"Schmelzer","year":"2009","journal-title":"J. Clin. Biochem. Nutr."},{"issue":"7","key":"10.1016\/j.prp.2025.156053_bib113","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.arcmed.2014.11.001","article-title":"Oral coenzyme Q10 supplementation in patients with nonalcoholic fatty liver disease: effects on serum vaspin, chemerin, pentraxin 3, insulin resistance and oxidative stress","volume":"45","author":"Farhangi","year":"2014","journal-title":"Arch. Med. Res."},{"issue":"4","key":"10.1016\/j.prp.2025.156053_bib114","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1080\/07315724.2015.1021057","article-title":"Functions of coenzyme Q10 supplementation on liver enzymes, markers of systemic inflammation, and adipokines in patients affected by nonalcoholic fatty liver disease: a double-blind, placebo-controlled, randomized clinical trial","volume":"35","author":"Farsi","year":"2016","journal-title":"J. Am. Coll. Nutr."},{"key":"10.1016\/j.prp.2025.156053_bib115","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.freeradbiomed.2013.03.022","article-title":"Role of vitamin E as a lipid-soluble peroxyl radical scavenger: in vitro and in vivo evidence","volume":"66","author":"Niki","year":"2014","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.prp.2025.156053_bib116","series-title":"Transplantation Proceedings","article-title":"editors. The protective effect of aprotinin and \u03b1-tocopherol on ischemia-reperfusion injury of the rat liver","author":"Polat","year":"2008"},{"issue":"5","key":"10.1016\/j.prp.2025.156053_bib117","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1007\/s00204-008-0394-7","article-title":"Effect of alpha-tocopherol on carbon tetrachloride intoxication in the rat liver","volume":"83","author":"Iida","year":"2009","journal-title":"Arch. Toxicol."},{"issue":"9","key":"10.1016\/j.prp.2025.156053_bib118","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1080\/00365520903114912","article-title":"Antioxidants vitamin E and 1-aminobenzotriazole prevent experimental non-alcoholic steatohepatitis in mice","volume":"44","author":"Nan","year":"2009","journal-title":"Scand. J. Gastroenterol."},{"issue":"18","key":"10.1016\/j.prp.2025.156053_bib119","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1056\/NEJMoa0907929","article-title":"Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis","volume":"362","author":"Sanyal","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.prp.2025.156053_bib120","doi-asserted-by":"crossref","DOI":"10.1111\/jgh.16723","article-title":"Vitamin E improves serum markers and histology in adults with metabolic dysfunction-associated steatotic liver disease: systematic review and meta-analysis","author":"Chee","year":"2024","journal-title":"J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.prp.2025.156053_bib121","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1164512","article-title":"Vitamin D3 alleviates nonalcoholic fatty liver disease in rats by inhibiting hepatic oxidative stress and inflammation via the SREBP-1-c\/PPAR\u03b1-NF-\u03baB\/IR-S2 signaling pathway","volume":"14","author":"Reda","year":"2023","journal-title":"Front Pharm."},{"issue":"6","key":"10.1016\/j.prp.2025.156053_bib122","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.numecd.2015.02.011","article-title":"A role of 1, 25 (OH) 2D3 supplementation in rats with nonalcoholic steatohepatitis induced by choline-deficient diet","volume":"25","author":"Han","year":"2015","journal-title":"Nutr., Metab. Cardiovasc. Dis."},{"issue":"4","key":"10.1016\/j.prp.2025.156053_bib123","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.clinre.2019.10.007","article-title":"Active vitamin D impedes the progression of non-alcoholic fatty liver disease by inhibiting cell senescence in a rat model","volume":"44","author":"Ma","year":"2020","journal-title":"Clin. Res. Hepatol. Gastroenterol."},{"key":"10.1016\/j.prp.2025.156053_bib124","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1007\/s12020-014-0336-5","article-title":"Does vitamin D improve liver enzymes, oxidative stress, and inflammatory biomarkers in adults with non-alcoholic fatty liver disease? A randomized clinical trial","volume":"47","author":"Sharifi","year":"2014","journal-title":"Endocrine"},{"issue":"2","key":"10.1016\/j.prp.2025.156053_bib125","doi-asserted-by":"crossref","first-page":"175","DOI":"10.15403\/jgld.2014.1121.252.cap","article-title":"Effect of short-term vitamin D correction on hepatic steatosis as quantified by controlled attenuation parameter (CAP)","volume":"25","author":"Papapostoli","year":"2016","journal-title":"J. Gastrointest. Liver Dis."},{"issue":"12","key":"10.1016\/j.prp.2025.156053_bib126","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0168216","article-title":"Docosahexanoic acid plus vitamin D treatment improves features of NAFLD in children with serum vitamin D deficiency: results from a single centre trial","volume":"11","author":"Della Corte","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.prp.2025.156053_bib127","author":"GAO","year":"2012","journal-title":"Interactions Between Flavonoids, Vitamin C and Vitamin E in Protecting Membranes Against Oxidative Stress, University of Saskatchewan"},{"issue":"5","key":"10.1016\/j.prp.2025.156053_bib128","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1179\/135100010X12826446921464","article-title":"Vitamin C, resveratrol and lipoic acid actions on isolated rat liver mitochondria: all antioxidants but different","volume":"15","author":"Valdecantos","year":"2010","journal-title":"Redox Rep."},{"issue":"8","key":"10.1016\/j.prp.2025.156053_bib129","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1038\/s41366-018-0212-0","article-title":"Ascorbic acid inhibits visceral obesity and nonalcoholic fatty liver disease by activating peroxisome proliferator-activated receptor \u03b1 in high-fat-diet-fed C57BL\/6J mice","volume":"43","author":"Lee","year":"2019","journal-title":"Int. J. Obes."},{"issue":"3","key":"10.1016\/j.prp.2025.156053_bib130","first-page":"2450","article-title":"Ascorbic acid attenuates cell stress by activating the fibroblast growth factor 21\/fibroblast growth factor receptor 2\/adiponectin pathway in HepG2 cells","volume":"20","author":"Gu","year":"2019","journal-title":"Mol. Med. Rep."},{"issue":"6","key":"10.1016\/j.prp.2025.156053_bib131","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1111\/jgh.12520","article-title":"Associations between intakes of individual nutrients or whole food groups and non-alcoholic fatty liver disease among K orean adults","volume":"29","author":"Han","year":"2014","journal-title":"J. Gastroenterol. Hepatol."},{"issue":"10","key":"10.1016\/j.prp.2025.156053_bib132","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1097\/01.mcg.0000212608.59090.08","article-title":"Oxidant stress and antioxidant status among patients with nonalcoholic fatty liver disease (NAFLD)","volume":"40","author":"Madan","year":"2006","journal-title":"J. Clin. Gastroenterol."},{"issue":"5","key":"10.1016\/j.prp.2025.156053_bib133","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.3390\/nu11051039","article-title":"Dietary polyphenols\u2014Important non-nutrients in the prevention of chronic noncommunicable diseases. A systematic review","volume":"11","author":"Koch","year":"2019","journal-title":"Nutrients"},{"issue":"16","key":"10.1016\/j.prp.2025.156053_bib134","doi-asserted-by":"crossref","first-page":"2439","DOI":"10.3390\/foods11162439","article-title":"The antioxidant and anti-inflammatory effects of flavonoids from propolis via Nrf2 and NF-\u03baB pathways","volume":"11","author":"Xu","year":"2022","journal-title":"Foods"},{"issue":"1","key":"10.1016\/j.prp.2025.156053_bib135","doi-asserted-by":"crossref","DOI":"10.1111\/cpr.13346","article-title":"Polyphenols as potential metabolism mechanisms regulators in liver protection and liver cancer prevention","volume":"56","author":"Li","year":"2023","journal-title":"Cell Prolif."},{"issue":"4","key":"10.1016\/j.prp.2025.156053_bib136","doi-asserted-by":"crossref","DOI":"10.1051\/bmdcn\/2019090423","article-title":"Curcumin reduces malondialdehyde and improves antioxidants in humans with diseased conditions: a comprehensive meta-analysis of randomized controlled trials","volume":"9","author":"Alizadeh","year":"2019","journal-title":"BioMedicine"},{"key":"10.1016\/j.prp.2025.156053_bib137","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.fsi.2019.12.074","article-title":"Optimal dietary curcumin improved growth performance, and modulated innate immunity, antioxidant capacity and related genes expression of NF-\u03baB and Nrf2 signaling pathways in grass carp (Ctenopharyngodon idella) after infection with Aeromonas hydrophila","volume":"97","author":"Ming","year":"2020","journal-title":"Fish. Shellfish Immunol."},{"key":"10.1016\/j.prp.2025.156053_bib138","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12986-019-0410-3","article-title":"Curcumin prevents high-fat diet-induced hepatic steatosis in ApoE\u2212\/\u2212 mice by improving intestinal barrier function and reducing endotoxin and liver TLR4\/NF-\u03baB inflammation","volume":"16","author":"Feng","year":"2019","journal-title":"Nutr. Metab."},{"key":"10.1016\/j.prp.2025.156053_bib139","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12986-019-0331-1","article-title":"Nano-curcumin improves glucose indices, lipids, inflammation, and Nesfatin in overweight and obese patients with non-alcoholic fatty liver disease (NAFLD): a double-blind randomized placebo-controlled clinical trial","volume":"16","author":"Jazayeri-Tehrani","year":"2019","journal-title":"Nutr. Metab."},{"key":"10.1016\/j.prp.2025.156053_bib140","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.biopha.2018.05.135","article-title":"Curcumin regulates endogenous and exogenous metabolism via Nrf2-FXR-LXR pathway in NAFLD mice","volume":"105","author":"Yan","year":"2018","journal-title":"Biomed. Pharmacother."},{"issue":"1","key":"10.1016\/j.prp.2025.156053_bib141","doi-asserted-by":"crossref","first-page":"71","DOI":"10.3892\/br.2012.27","article-title":"Quercetin improves insulin resistance and hepatic lipid accumulation in vitro in a NAFLD cell model","volume":"1","author":"Li","year":"2013","journal-title":"Biomed. Rep."},{"issue":"16","key":"10.1016\/j.prp.2025.156053_bib142","doi-asserted-by":"crossref","first-page":"1800164","DOI":"10.1002\/mnfr.201800164","article-title":"Frataxin-Mediated PINK1\u2013Parkin-dependent mitophagy in hepatic steatosis: the protective effects of quercetin","volume":"62","author":"Liu","year":"2018","journal-title":"Mol. Nutr. Food Res."},{"issue":"2","key":"10.1016\/j.prp.2025.156053_bib143","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/j.tiv.2013.01.014","article-title":"Quercetin ameliorate insulin resistance and up-regulates cellular antioxidants during oleic acid induced hepatic steatosis in HepG2 cells","volume":"27","author":"Vidyashankar","year":"2013","journal-title":"Toxicol. In Vitro"},{"key":"10.1016\/j.prp.2025.156053_bib144","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.fct.2018.02.019","article-title":"Quercetin ameliorates HFD-induced NAFLD by promoting hepatic VLDL assembly and lipophagy via the IRE1a\/XBP1s pathway","volume":"114","author":"Zhu","year":"2018","journal-title":"Food Chem. Toxicol."},{"issue":"6","key":"10.1016\/j.prp.2025.156053_bib145","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.3945\/jn.111.157263","article-title":"Quercetin ameliorates cardiovascular, hepatic, and metabolic changes in diet-induced metabolic syndrome in rats","volume":"142","author":"Panchal","year":"2012","journal-title":"J. Nutr."},{"issue":"12","key":"10.1016\/j.prp.2025.156053_bib146","first-page":"386","article-title":"Effects of comprehensive treatment with quercetin administration on biochemical blood parameters and pro-and anti-inflammatory cytokines in nonalcoholic fatty liver disease patients","volume":"6","author":"Prysyazhnyuk","year":"2017","journal-title":"Pharma Innov. J."},{"key":"10.1016\/j.prp.2025.156053_bib147","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.freeradbiomed.2016.11.037","article-title":"Protective effect of quercetin on high-fat diet-induced non-alcoholic fatty liver disease in mice is mediated by modulating intestinal microbiota imbalance and related gut-liver axis activation","volume":"102","author":"Porras","year":"2017","journal-title":"Free Radic. Biol. Med."},{"issue":"3","key":"10.1016\/j.prp.2025.156053_bib148","doi-asserted-by":"crossref","first-page":"933","DOI":"10.3390\/nu13030933","article-title":"The role of resveratrol in liver disease: a comprehensive review from in vitro to clinical trials","volume":"13","author":"Izzo","year":"2021","journal-title":"Nutrients"},{"issue":"9","key":"10.1016\/j.prp.2025.156053_bib149","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1007\/s12272-014-0347-z","article-title":"Protective effect of resveratrol derivatives on high-fat diet induced fatty liver by activating AMP-activated protein kinase","volume":"37","author":"Choi","year":"2014","journal-title":"Arch. Pharm. Res"},{"issue":"7","key":"10.1016\/j.prp.2025.156053_bib150","doi-asserted-by":"crossref","first-page":"967","DOI":"10.2174\/1871520611313070001","article-title":"Inhibition of PI3K\/Akt\/mTOR signaling by natural products","volume":"13","author":"Huang","year":"2013","journal-title":"Anticancer Agents Med. Chem."},{"issue":"7117","key":"10.1016\/j.prp.2025.156053_bib151","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/nature05354","article-title":"Resveratrol improves health and survival of mice on a high-calorie diet","volume":"444","author":"Baur","year":"2006","journal-title":"Nature"},{"issue":"12","key":"10.1016\/j.prp.2025.156053_bib152","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1139\/cjpp-2016-0561","article-title":"The beneficial effects of resveratrol on steatosis and mitochondrial oxidative stress in HepG2 cells","volume":"95","author":"Izdebska","year":"2017","journal-title":"Can. J. Physiol. Pharmacol."},{"issue":"1","key":"10.1016\/j.prp.2025.156053_bib153","doi-asserted-by":"crossref","DOI":"10.1136\/bmjgast-2020-000381","article-title":"SIRT1-dependent mechanisms and effects of resveratrol for amelioration of muscle wasting in NASH mice","volume":"7","author":"Liu","year":"2020","journal-title":"BMJ Open Gastroenterol."},{"key":"10.1016\/j.prp.2025.156053_bib154","doi-asserted-by":"crossref","DOI":"10.1016\/j.biocel.2019.105667","article-title":"Resveratrol alleviates non-alcoholic fatty liver disease through epigenetic modification of the Nrf2 signaling pathway","volume":"119","author":"Hosseini","year":"2020","journal-title":"Int. J. Biochem. Cell Biol."},{"issue":"10","key":"10.1016\/j.prp.2025.156053_bib155","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/j.nutres.2014.09.005","article-title":"Resveratrol supplementation improves inflammatory biomarkers in patients with nonalcoholic fatty liver disease","volume":"34","author":"Faghihzadeh","year":"2014","journal-title":"Nutr. Res."},{"issue":"2","key":"10.1016\/j.prp.2025.156053_bib156","doi-asserted-by":"crossref","first-page":"307","DOI":"10.15171\/apb.2018.036","article-title":"Effects of PHarmacologic Dose of Resveratrol Supplementation on Oxidative\/antioxidative Status Biomarkers in Nonalcoholic Fatty Liver Disease Patients: A Randomized, Double-blind, Placebo-controlled Trial","volume":"8","author":"Asghari","year":"2018","journal-title":"Adv. Pharm. Bull."},{"key":"10.1016\/j.prp.2025.156053_bib157","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctcp.2020.101281","article-title":"Efficacy of resveratrol supplementation in patients with nonalcoholic fatty liver disease: a systematic review and meta-analysis of clinical trials","volume":"42","author":"Rafiee","year":"2021","journal-title":"Complement Ther. Clin. Pract."},{"issue":"1","key":"10.1016\/j.prp.2025.156053_bib158","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1080\/07853890.2022.2069854","article-title":"Role of silymarin as antioxidant in clinical management of chronic liver diseases: a narrative review","volume":"54","author":"Aghemo","year":"2022","journal-title":"Ann. Med."},{"key":"10.1016\/j.prp.2025.156053_bib159","first-page":"1","article-title":"Hepatoprotective effect of silymarin on fructose induced nonalcoholic fatty liver disease in male albino wistar rats","volume":"21","author":"Mengesha","year":"2021","journal-title":"BMC Complement. Med. Ther."},{"issue":"6","key":"10.1016\/j.prp.2025.156053_bib160","doi-asserted-by":"crossref","DOI":"10.1111\/jfbc.13194","article-title":"Silymarin attenuated nonalcoholic fatty liver disease through the regulation of endoplasmic reticulum stress proteins GRP78 and XBP-1 in mice","volume":"44","author":"Sahin","year":"2020","journal-title":"J. Food Biochem."},{"issue":"3","key":"10.1016\/j.prp.2025.156053_bib161","doi-asserted-by":"crossref","first-page":"324","DOI":"10.3390\/antiox13030324","article-title":"Silybin alleviated hepatic injury by regulating redox balance, inflammatory response, and mitochondrial function in weaned piglets under paraquat-induced oxidative stress","volume":"13","author":"Cai","year":"2024","journal-title":"Antioxidants"},{"issue":"4","key":"10.1016\/j.prp.2025.156053_bib162","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.apsb.2019.02.006","article-title":"Silibinin ameliorates hepatic lipid accumulation and oxidative stress in mice with non-alcoholic steatohepatitis by regulating CFLAR-JNK pathway","volume":"9","author":"Liu","year":"2019","journal-title":"Acta Pharm. Sin. B"},{"issue":"10","key":"10.1016\/j.prp.2025.156053_bib163","doi-asserted-by":"crossref","first-page":"544","DOI":"10.3390\/medicina56100544","article-title":"Silymarin in combination with vitamin C, vitamin E, coenzyme Q10 and selenomethionine to improve liver enzymes and blood lipid profile in NAFLD patients","volume":"56","author":"Curcio","year":"2020","journal-title":"Medicina"},{"issue":"6","key":"10.1016\/j.prp.2025.156053_bib164","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.trsl.2011.12.003","article-title":"Silibinin modulates lipid homeostasis and inhibits nuclear factor kappa B activation in experimental nonalcoholic steatohepatitis","volume":"159","author":"Salamone","year":"2012","journal-title":"Transl. Res."},{"key":"10.1016\/j.prp.2025.156053_bib165","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.1049818","article-title":"Naringin attenuates fructose-induced NAFLD progression in rats through reducing endogenous triglyceride synthesis and activating the Nrf2\/HO-1 pathway","volume":"13","author":"Pengnet","year":"2022","journal-title":"Front Pharm."},{"key":"10.1016\/j.prp.2025.156053_bib166","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1743-7075-12-1","article-title":"The flavonoid, naringenin, decreases adipose tissue mass and attenuates ovariectomy-associated metabolic disturbances in mice","volume":"12","author":"Ke","year":"2015","journal-title":"Nutr. Metab."},{"key":"10.1016\/j.prp.2025.156053_bib167","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.ejphar.2014.10.027","article-title":"Naringenin reduces cholesterol-induced hepatic inflammation in rats by modulating matrix metalloproteinases-2, 9 via inhibition of nuclear factor \u03baB pathway","volume":"746","author":"Chtourou","year":"2015","journal-title":"Eur. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.prp.2025.156053_bib168","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1146\/annurev.nutr.22.111401.144957","article-title":"Dietary flavonoids: bioavailability, metabolic effects, and safety","volume":"22","author":"Ross","year":"2002","journal-title":"Annu. Rev. Nutr."},{"issue":"2","key":"10.1016\/j.prp.2025.156053_bib169","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1002\/ptr.6865","article-title":"Rosmarinic acid exerts an antagonistic effect on nonalcoholic fatty liver disease by regulating the YAP1\/TAZ-PPAR\u03b3\/PGC-1\u03b1 signaling pathway","volume":"35","author":"Luo","year":"2021","journal-title":"Phytother. Res."},{"issue":"6","key":"10.1016\/j.prp.2025.156053_bib170","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.3945\/jn.111.137877","article-title":"Rutin attenuates metabolic changes, nonalcoholic steatohepatitis, and cardiovascular remodeling in high-carbohydrate, high-fat diet-fed rats","volume":"141","author":"Panchal","year":"2011","journal-title":"J. Nutr."},{"issue":"1","key":"10.1016\/j.prp.2025.156053_bib171","doi-asserted-by":"crossref","first-page":"92","DOI":"10.3390\/antiox11010092","article-title":"Gallic acid improves diabetic steatosis by downregulating microRNA-34a-5p through targeting NFE2L2 expression in high-fat diet-fed db\/db mice","volume":"11","author":"Lee","year":"2021","journal-title":"Antioxidants"},{"issue":"15","key":"10.1016\/j.prp.2025.156053_bib172","doi-asserted-by":"crossref","first-page":"3591","DOI":"10.1111\/bph.15083","article-title":"Cyanidin-3-O-glucoside improves non-alcoholic fatty liver disease by promoting PINK1-mediated mitophagy in mice","volume":"177","author":"Li","year":"2020","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.prp.2025.156053_bib173","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2022.154561","article-title":"Pterostilbene alleviated NAFLD via AMPK\/mTOR signaling pathways and autophagy by promoting Nrf2","volume":"109","author":"Shen","year":"2023","journal-title":"Phytomedicine"},{"issue":"11","key":"10.1016\/j.prp.2025.156053_bib174","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1111\/j.1440-1746.2006.04681.x","article-title":"Preventive role of genistein in an experimental non-alcoholic steatohepatitis model","volume":"22","author":"Yalniz","year":"2007","journal-title":"J. Gastroenterol. Hepatol."},{"issue":"3","key":"10.1016\/j.prp.2025.156053_bib175","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1096\/fj.201700231RR","article-title":"Vanillic acid attenuates obesity via activation of the AMPK pathway and thermogenic factors in vivo and in vitro","volume":"32","author":"Jung","year":"2018","journal-title":"FASEB J."},{"issue":"1","key":"10.1016\/j.prp.2025.156053_bib176","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.bcp.2014.07.002","article-title":"Troxerutin improves hepatic lipid homeostasis by restoring NAD+\u2009-depletion-mediated dysfunction of lipin 1 signaling in high-fat diet-treated mice","volume":"91","author":"Zhang","year":"2014","journal-title":"Biochem. Pharmacol."},{"issue":"8pt2","key":"10.1016\/j.prp.2025.156053_bib177","doi-asserted-by":"crossref","first-page":"e465","DOI":"10.1111\/j.1440-1746.2007.05052.x","article-title":"Epigallocatechin gallate attenuates experimental non-alcoholic steatohepatitis induced by high fat diet","volume":"23","author":"Kuzu","year":"2008","journal-title":"J. Gastroenterol. Hepatol."},{"issue":"1","key":"10.1016\/j.prp.2025.156053_bib178","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.bbrc.2011.11.102","article-title":"Theaflavin attenuates ischemia\u2013reperfusion injury in a mouse fatty liver model","volume":"417","author":"Luo","year":"2012","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"4","key":"10.1016\/j.prp.2025.156053_bib179","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.dld.2011.11.010","article-title":"Silibinin improves hepatic and myocardial injury in mice with nonalcoholic steatohepatitis","volume":"44","author":"Salamone","year":"2012","journal-title":"Dig. Liver Dis."},{"key":"10.1016\/j.prp.2025.156053_bib180","doi-asserted-by":"crossref","DOI":"10.3389\/fnut.2021.640557","article-title":"The impact of macronutrient intake on non-alcoholic fatty liver disease (NAFLD): too much fat, too much carbohydrate, or just too many calories?","volume":"8","author":"Hydes","year":"2021","journal-title":"Front. Nutr."},{"issue":"7","key":"10.1016\/j.prp.2025.156053_bib181","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/j.jacc.2020.05.077","article-title":"Saturated fats and health: a reassessment and proposal for food-based recommendations: JACC state-of-the-art review","volume":"76","author":"Astrup","year":"2020","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.prp.2025.156053_bib182","doi-asserted-by":"crossref","DOI":"10.1016\/j.fct.2020.111558","article-title":"Analysis of the intricate effects of polyunsaturated fatty acids and polyphenols on inflammatory pathways in health and disease","volume":"143","author":"Margin\u0103","year":"2020","journal-title":"Food Chem. Toxicol."},{"issue":"5","key":"10.1016\/j.prp.2025.156053_bib183","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.3390\/nu13051442","article-title":"Overview of non-alcoholic fatty liver disease (NAFLD) and the role of sugary food consumption and other dietary components in its development","volume":"13","author":"Vancells Lujan","year":"2021","journal-title":"Nutrients"},{"issue":"1","key":"10.1016\/j.prp.2025.156053_bib184","doi-asserted-by":"crossref","first-page":"61","DOI":"10.3390\/jpm14010061","article-title":"Non-pharmacological approach to diet and exercise in metabolic-associated fatty liver disease: bridging the gap between research and clinical practice","volume":"14","author":"Ali","year":"2024","journal-title":"J. Pers. Med."},{"issue":"3","key":"10.1016\/j.prp.2025.156053_bib185","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1080\/09637486.2021.1979478","article-title":"The effect of a Mediterranean diet vs. a low-fat diet on non-alcoholic fatty liver disease in children: a randomized trial","volume":"73","author":"Akbulut","year":"2022","journal-title":"Int. J. Food Sci. Nutr."},{"issue":"10","key":"10.1016\/j.prp.2025.156053_bib186","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.3390\/nu9101052","article-title":"Mediterranean diet and multi-ingredient-based interventions for the management of non-alcoholic fatty liver disease","volume":"9","author":"Su\u00e1rez","year":"2017","journal-title":"Nutrients"},{"issue":"9","key":"10.1016\/j.prp.2025.156053_bib187","doi-asserted-by":"crossref","first-page":"2864","DOI":"10.3390\/nu12092864","article-title":"Effects of dietary and lifestyle interventions on liver, clinical and metabolic parameters in children and adolescents with non-alcoholic fatty liver disease: a systematic review","volume":"12","author":"Katsagoni","year":"2020","journal-title":"Nutrients"},{"key":"10.1016\/j.prp.2025.156053_bib188","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2023.101675","article-title":"A low-carbohydrate diet induces hepatic insulin resistance and metabolic associated fatty liver disease in mice","volume":"69","author":"Long","year":"2023","journal-title":"Mol. Metab."},{"issue":"33","key":"10.1016\/j.prp.2025.156053_bib189","doi-asserted-by":"crossref","first-page":"4814","DOI":"10.3748\/wjg.v25.i33.4814","article-title":"Intestinal permeability in the pathogenesis of liver damage: from non-alcoholic fatty liver disease to liver transplantation","volume":"25","author":"Nicoletti","year":"2019","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.prp.2025.156053_bib190","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.aninu.2023.06.004","article-title":"Regulation of dietary fiber on intestinal microorganisms and its effects on animal health","volume":"14","author":"Han","year":"2023","journal-title":"Anim. Nutr."},{"issue":"12","key":"10.1016\/j.prp.2025.156053_bib191","doi-asserted-by":"crossref","first-page":"3216","DOI":"10.1039\/C4FO00549J","article-title":"Lactobacillus plantarum NCU116 improves liver function, oxidative stress and lipid metabolism in rats with high fat diet induced non-alcoholic fatty liver disease","volume":"5","author":"Li","year":"2014","journal-title":"Food Funct."},{"key":"10.1016\/j.prp.2025.156053_bib192","doi-asserted-by":"crossref","first-page":"5843","DOI":"10.1007\/s00253-019-09703-4","article-title":"Lactobacillus plantarum NA136 improves the non-alcoholic fatty liver disease by modulating the AMPK\/Nrf2 pathway","volume":"103","author":"Zhao","year":"2019","journal-title":"Appl. Microbiol. Biotechnol."},{"issue":"1","key":"10.1016\/j.prp.2025.156053_bib193","article-title":"Dietary blueberry and bifidobacteria attenuate nonalcoholic fatty liver disease in rats by affecting SIRT1-mediated signaling pathway","volume":"2014","author":"Ren","year":"2014","journal-title":"Oxid. Med. Cell. Longev."},{"issue":"1","key":"10.1016\/j.prp.2025.156053_bib194","doi-asserted-by":"crossref","first-page":"72","DOI":"10.3164\/jcbn.11-38","article-title":"Supplementation with probiotics modifies gut flora and attenuates liver fat accumulation in rat nonalcoholic fatty liver disease model","volume":"50","author":"Xu","year":"2011","journal-title":"J. Clin. Biochem. Nutr."},{"issue":"7","key":"10.1016\/j.prp.2025.156053_bib195","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1038\/ismej.2017.24","article-title":"Faecalibacterium prausnitzii treatment improves hepatic health and reduces adipose tissue inflammation in high-fat fed mice","volume":"11","author":"Munukka","year":"2017","journal-title":"ISME J."},{"key":"10.1016\/j.prp.2025.156053_bib196","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1007\/s13167-017-0117-3","article-title":"Comparative study of probiotic effects of Lactobacillus and Bifidobacteria strains on cholesterol levels, liver morphology and the gut microbiota in obese mice","volume":"8","author":"Bubnov","year":"2017","journal-title":"EPMA J."},{"key":"10.1016\/j.prp.2025.156053_bib197","doi-asserted-by":"crossref","first-page":"6817","DOI":"10.1007\/s00253-014-5752-1","article-title":"Preventing non-alcoholic fatty liver disease through Lactobacillus johnsonii BS15 by attenuating inflammation and mitochondrial injury and improving gut environment in obese mice","volume":"98","author":"Xin","year":"2014","journal-title":"Appl. Microbiol. Biotechnol."},{"issue":"6","key":"10.1016\/j.prp.2025.156053_bib198","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1080\/07315724.2015.1031355","article-title":"Effects of multistrain probiotic supplementation on glycemic and inflammatory indices in patients with nonalcoholic fatty liver disease: a double-blind randomized clinical trial","volume":"35","author":"Sepideh","year":"2016","journal-title":"J. Am. Coll. Nutr."},{"issue":"5","key":"10.1016\/j.prp.2025.156053_bib199","first-page":"531","article-title":"Effect of a probiotic and metformin on liver aminotransferases in non-alcoholic steatohepatitis: a double blind randomized clinical trial","volume":"4","author":"Shavakhi","year":"2013","journal-title":"Int. J. Prev. Med."},{"issue":"1","key":"10.1016\/j.prp.2025.156053_bib200","doi-asserted-by":"crossref","first-page":"5688","DOI":"10.1038\/s41598-019-42059-3","article-title":"Randomized, double-blind, placebo-controlled study of a multispecies probiotic mixture in nonalcoholic fatty liver disease","volume":"9","author":"Ahn","year":"2019","journal-title":"Sci. Rep."},{"issue":"9","key":"10.1016\/j.prp.2025.156053_bib201","first-page":"1090","article-title":"Effect of a probiotic on liver aminotransferases in nonalcoholic fatty liver disease patients: a double blind randomized clinical trial","volume":"15","author":"Aller","year":"2011","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"issue":"3","key":"10.1016\/j.prp.2025.156053_bib202","doi-asserted-by":"crossref","DOI":"10.1111\/eci.13622","article-title":"Mitochondria, oxidative stress and nonalcoholic fatty liver disease: a complex relationship","volume":"52","author":"Karkucinska-Wieckowska","year":"2022","journal-title":"Eur. J. Clin. Investig."},{"issue":"10","key":"10.1016\/j.prp.2025.156053_bib203","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1111\/j.1478-3231.2011.02604.x","article-title":"Antioxidants as therapeutic agents for liver disease","volume":"31","author":"Singal","year":"2011","journal-title":"Liver Int."},{"key":"10.1016\/j.prp.2025.156053_bib204","article-title":"Using controlled clinical trials to learn more about acute drug-induced liver injury","author":"Watkins","year":"2008","journal-title":"Wiley Online Libr."},{"issue":"2","key":"10.1016\/j.prp.2025.156053_bib205","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/sj.bjp.0705776","article-title":"Measuring reactive species and oxidative damage in vivo and in cell culture: how should you do it and what do the results mean?","volume":"142","author":"Halliwell","year":"2004","journal-title":"Br. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.prp.2025.156053_bib206","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1080\/00365520701559003","article-title":"Blood oxidative stress markers in non-alcoholic steatohepatitis and how it correlates with diet","volume":"43","author":"Machado","year":"2008","journal-title":"Scand. J. Gastroenterol."},{"issue":"1","key":"10.1016\/j.prp.2025.156053_bib207","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/j.1365-2036.2006.02719.x","article-title":"Blood oxidative stress markers are unreliable markers of hepatic steatosis","volume":"23","author":"Bonnefont-Rousselot","year":"2006","journal-title":"Aliment. Pharmacol. Ther."},{"issue":"1","key":"10.1016\/j.prp.2025.156053_bib208","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.tox.2009.11.008","article-title":"Curcumin, resveratrol and flavonoids as anti-inflammatory, cyto-and DNA-protective dietary compounds","volume":"278","author":"Bisht","year":"2010","journal-title":"Toxicology"},{"issue":"1","key":"10.1016\/j.prp.2025.156053_bib209","doi-asserted-by":"crossref","first-page":"204","DOI":"10.3390\/antiox4010204","article-title":"Silymarin as a natural antioxidant: an overview of the current evidence and perspectives","volume":"4","author":"Surai","year":"2015","journal-title":"Antioxidants"},{"issue":"5","key":"10.1016\/j.prp.2025.156053_bib210","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/0891-5849(94)00238-F","article-title":"Protection of vitamin E, selenium, trolox C, ascorbic acid palmitate, acetylcysteine, coenzyme Q0, coenzyme Q10, beta-carotene, canthaxanthin, and (+)-catechin against oxidative damage to rat blood and tissues in vivo","volume":"18","author":"Chen","year":"1995","journal-title":"Free Radic. Biol. Med."},{"issue":"1","key":"10.1016\/j.prp.2025.156053_bib211","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.abb.2003.12.025","article-title":"Antioxidant and prooxidant properties of mitochondrial Coenzyme Q","volume":"423","author":"James","year":"2004","journal-title":"Arch. Biochem. Biophys."},{"issue":"4","key":"10.1016\/j.prp.2025.156053_bib212","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1080\/10408398.2014.952399","article-title":"The potential of flavonoids in the treatment of non-alcoholic fatty liver disease","volume":"57","author":"Van De Wier","year":"2017","journal-title":"Crit. Rev. Food Sci. Nutr."},{"issue":"14","key":"10.1016\/j.prp.2025.156053_bib213","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.3390\/foods11142169","article-title":"Total flavonoids from Chimonanthus nitens Oliv. leaves ameliorate HFD-induced NAFLD by regulating the gut\u2013liver axis in mice","volume":"11","author":"Meng","year":"2022","journal-title":"Foods"},{"issue":"6","key":"10.1016\/j.prp.2025.156053_bib214","doi-asserted-by":"crossref","first-page":"956","DOI":"10.3390\/nu17060956","article-title":"Clinical insights into non-alcoholic fatty liver disease and the therapeutic potential of flavonoids: an update","volume":"17","author":"Koz\u0142owska","year":"2025","journal-title":"Nutrients"},{"issue":"8","key":"10.1016\/j.prp.2025.156053_bib215","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1080\/10715760410001727858","article-title":"Pharmacokinetics and metabolism of dietary flavonoids in humans","volume":"38","author":"Manach","year":"2004","journal-title":"Free Radic. Res."},{"issue":"1","key":"10.1016\/j.prp.2025.156053_bib216","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1207\/s15327914nc5001_1","article-title":"Dietary flavonoids and cancer risk: evidence from human population studies","volume":"50","author":"Neuhouser","year":"2004","journal-title":"Nutr. Cancer"},{"issue":"11","key":"10.1016\/j.prp.2025.156053_bib217","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1002\/ptr.5447","article-title":"Recent trends in preclinical drug\u2013drug interaction studies of flavonoids\u2014Review of case studies, issues and perspectives","volume":"29","author":"Srinivas","year":"2015","journal-title":"Phytother. Res."}],"container-title":["Pathology - Research and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033825002468?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033825002468?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,29]],"date-time":"2025-07-29T14:35:46Z","timestamp":1753799746000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0344033825002468"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":217,"alternative-id":["S0344033825002468"],"URL":"https:\/\/doi.org\/10.1016\/j.prp.2025.156053","relation":{},"ISSN":["0344-0338"],"issn-type":[{"value":"0344-0338","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Combating oxidative stress in non-alcoholic fatty liver disease: From mechanisms to therapeutic strategies","name":"articletitle","label":"Article Title"},{"value":"Pathology - Research and Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prp.2025.156053","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier GmbH. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"156053"}}